Our services
Request an appointment
Reserve your spot with our medical team in just minutes.
Your body’s energy doesn’t come from willpower or coffee – it comes from mitochondria, the powerhouse of the cell. When they start to wear down, you’ll feel it: constant tiredness even after sleep, muscles that take forever to recover from workouts, brain fog that coffee can’t fix, and the sense that you’re somehow aging faster than your friends.
Sounds like you?
Medical Cosmetic Enhancements in Washington DC has been helping patients address these issues since 2003, and now offers SS-31 (Elamipretide) as part of its regenerative peptide therapy program. If you live in DC, Arlington, Bethesda, or McLean, this option is very much worth knowing about.
What Is SS-31?
SS-31, known pharmaceutically as Elamipretide, is a short peptide engineered to do one specific job: travel inside your mitochondria and stabilize the structures that produce cellular energy. You can think of your mitochondria as power plants, and cardiolipin as the scaffolding that holds the generators in place. When cardiolipin degrades – which can happen from age, stress, and certain medical conditions – the entire plant becomes unstable. SS-31 basically shores up that scaffolding, helping your mitochondria work the way they’re supposed to.
In 2025, the FDA approved Elamipretide under the brand name Forzinity for the treatment of Barth syndrome, a rare inherited condition that damages mitochondria in the heart. This is a meaningful regulatory milestone. The vast majority of peptides marketed for energy, recovery, or longevity have never undergone FDA review (MIT Technology Review). Elamipretide has — and it earned that approval thanks to its observable benefits.
Now, using SS-31 for general energy optimization and recovery sits outside that original FDA approval – what doctors call “off-label” use. This is completely legal and happens constantly in medicine (aspirin was originally approved for pain, now we use it for heart health). But it’s important you know the difference.
At Medical Cosmetic Enhancements, every patient receives a full medical evaluation and a clear consent conversation before starting any peptide protocol, including SS-31.
What the FDA Approval Means for Wellness Use
The 2025 FDA approval of Elamipretide is significant for the wellness and functional medicine space, but it comes with important nuance. As noted by regulatory experts, Category 1 reclassification (or FDA approval) for a rare disease indication does not automatically mean broad off-label use is without risk or regulatory complexity. Approved drugs may be prescribed off-label at a physician’s discretion, but:
- Long-term safety data outside the Barth syndrome population is still developing
- Sourcing must come from licensed, regulated pharmacies – not gray-market vendors
- Physician oversight, informed consent, and lab monitoring are non-negotiable
At Medical Cosmetic Enhancements, SS-31 is offered only within this framework.
How SS-31 Fits the Broader Wellness Picture
|
Concern
|
How SS-31 May Help
|
|---|---|
|
Persistent fatigue |
Restores ATP efficiency at the mitochondrial level |
|
Slow exercise recovery |
Reduces oxidative damage in muscle tissue post-exertion |
|
Mental fog / cognitive decline |
Supports neuronal energy supply |
|
Age-related metabolic decline |
Addresses a root driver of cellular aging |
|
GLP-1 / weight loss protocols |
Maintains energy during caloric deficit phases |
Patients working through our semaglutide-based weight loss program often find mitochondrial support helps sustain energy during caloric deficit phases. Those combining SS-31 with Sermorelin therapy report compounding benefits on recovery and physical resilience.
Who May Benefit
SS-31 therapy is worth exploring for:
- Adults noticing progressive energy decline despite adequate sleep and nutrition
- Patients recovering from prolonged illness or significant metabolic stress
- Individuals on body composition protocols who want cellular-level energy support
- Those experiencing noticeably longer recovery times with age
- Patients already using peptides like Sermorelin who want to optimize their foundational energy systems
Frequently Asked Questions
Yes – Elamipretide (SS-31) received FDA approval in 2025 under the brand name Forzinity for Barth syndrome, a rare mitochondrial cardiomyopathy. Use for energy optimization and recovery is off-label, which is legal under physician supervision but should be clearly understood by patients before starting.
No. Unlike CoQ10 or Vitamin C, SS-31 physically accumulates inside the mitochondria and repairs the structural lipid that anchors the electron transport chain. Its mechanism is architectural, not scavenger-based.
Subcutaneous injection, typically once daily. Our team provides full training on self-administration after an initial in-clinic visit at our Washington, DC office.
Some patients notice improved energy and exercise endurance within the first few weeks; others see more gradual improvement over two to three months. Consistent use and lifestyle support both matter significantly.
Yes, and it is often part of a broader protocol alongside Sermorelin or discussed in combination with other FDA-approved or legally compoundable peptides, depending on a patient's individual goals.
Take the Next Step
Fatigue that does not respond to rest is a signal worth taking seriously. SS-31 (Elamipretide) addresses one of the most foundational causes of age-related energy decline – mitochondrial membrane degradation – with a level of scientific credibility and regulatory standing that very few peptides in the wellness space can claim. Medical Cosmetic Enhancements brings this FDA-approved regenerative therapy to Washington, DC and the surrounding metro area under full physician supervision.
Call (202) 621-8675 or request a complimentary consultation to find out whether SS-31 belongs in your wellness protocol.